EFFECTS OF RITANSERIN, A SPECIFIC SEROTONIN-S-2 RECEPTOR ANTAGONIST, ON THE RELEASE OF ANTERIOR-PITUITARY HORMONES DURING INSULIN-INDUCED HYPOGLYCEMIA IN NORMAL HUMANS
D. Tepavcevic et al., EFFECTS OF RITANSERIN, A SPECIFIC SEROTONIN-S-2 RECEPTOR ANTAGONIST, ON THE RELEASE OF ANTERIOR-PITUITARY HORMONES DURING INSULIN-INDUCED HYPOGLYCEMIA IN NORMAL HUMANS, Journal of endocrinological investigation, 18(6), 1995, pp. 427-430
The role of serotonin in the insulin hypoglycemia (IH) stimulated secr
etion of prolactin (PRL), growth hormone (GH), adrenocorticotropin (AC
TH) and cortisol (F) was studied in a group of 12 normal subjects duri
ng the control period after placebo and a consecutive six-day treatmen
t with 20 mg ritanserin (RIT) per day, RIT failed to affect the baseli
ne levels of ail the four hormones as well as the PRL response to IH (
p>0.5). The serum GH response to IH was moderately diminished after RI
T, the reduction of integrated trapezoidal area under hormone curves (
nAUC) being 50.7% +/- 6.9% (p<0.005). Furthermore, RIT was found to sl
ightly decrease the plasma ACTH response to IH, the reduction of nAUC
being 36.3% +/- 2.6% (p<0.005). Decrease in the corresponding plasma F
response to IH was accompanied by 29.1% +/- 2.4% reduction of nAUC (p
<0.005). According to our results, serotonin-S-2 receptors appeared to
be moderately involved in IH-induced release of GH, but slightly in t
hat of ACTH, leaving unaffected that of PRL.